These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30854441)

  • 1. Magnetization Transfer MRI of Breast Cancer in the Community Setting: Reproducibility and Preliminary Results in Neoadjuvant Therapy.
    Virostko J; Sorace AG; Wu C; Ekrut D; Jarrett AM; Upadhyaya RM; Avery S; Patt D; Goodgame B; Yankeelov TE
    Tomography; 2019 Mar; 5(1):44-52. PubMed ID: 30854441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of automated breast volume scanning with conventional ultrasonography, mammography, and MRI to assess residual breast cancer after neoadjuvant therapy by molecular type.
    Peng Y; Yuan F; Xie F; Yang H; Wang S; Wang C; Yang Y; Du W; Liu M; Wang S
    Clin Radiol; 2023 May; 78(5):e393-e400. PubMed ID: 36822980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetization transfer ratio: a potential biomarker for the assessment of postradiation fibrosis in patients with rectal cancer.
    Martens MH; Lambregts DM; Papanikolaou N; Heijnen LA; Riedl RG; zur Hausen A; Maas M; Beets GL; Beets-Tan RG
    Invest Radiol; 2014 Jan; 49(1):29-34. PubMed ID: 24002079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rate of breast fibroglandular enhancement during dynamic contrast-enhanced MRI reflects response to neoadjuvant therapy.
    Virostko J; Kuketz G; Higgins E; Wu C; Sorace AG; DiCarlo JC; Avery S; Patt D; Goodgame B; Yankeelov TE
    Eur J Radiol; 2021 Mar; 136():109534. PubMed ID: 33454460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.
    van Egdom LSE; Lagendijk M; Heijkoop EHM; Koning AHJ; van Deurzen CHM; Jager A; van Lankeren W; Koppert LB
    Eur J Radiol; 2018 Jul; 104():94-100. PubMed ID: 29857873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
    NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
    Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
    Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic variation of off-resonance prepulses for clinical magnetization transfer contrast imaging at 0.2, 1.5, and 3.0 tesla.
    Martirosian P; Boss A; Deimling M; Kiefer B; Schraml C; Schwenzer NF; Claussen CD; Schick F
    Invest Radiol; 2008 Jan; 43(1):16-26. PubMed ID: 18097273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetization transfer imaging to assess tumour response after chemoradiotherapy in rectal cancer.
    Martens MH; Lambregts DM; Papanikolaou N; Alefantinou S; Maas M; Manikis GC; Marias K; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Feb; 26(2):390-7. PubMed ID: 26065396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
    Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
    Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal magnetization transfer ratio at 3T: validation of automated postprocessing and comparison of quantification metrics.
    Sidharthan S; Hutten R; Glielmi C; Du H; Malone F; Ragin AB; Edelman RR; Wu Y
    J Neuroimaging; 2013 Jul; 23(3):484-90. PubMed ID: 22817911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing to imaging and surgery after neoadjuvant therapy for breast cancer.
    Grubstein A; Rapson Y; Stemmer SM; Allweis T; Wolff-Bar M; Borshtein S; Eden S; Tamir S; Atar E; Sharon E; Shochat T; Yerushalmi R
    Clin Imaging; 2021 Mar; 71():24-28. PubMed ID: 33171362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
    Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative assessment of residual disease in locally advanced breast cancer patients: A sequential study by quantitative diffusion weighted MRI as a function of therapy.
    Agarwal K; Sharma U; Sah RG; Mathur S; Hari S; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2017 Oct; 42():88-94. PubMed ID: 28627463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
    Namura M; Tsunoda H; Yagata H; Hayashi N; Yoshida A; Morishita E; Takei J; Suzuki K; Yamauchi H
    Clin Breast Cancer; 2018 Apr; 18(2):128-134. PubMed ID: 28843513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo magnetization transfer imaging of the lung using a zero echo time sequence at 4.7 Tesla in mice: Initial experience.
    Wurnig MC; Weiger M; Wu M; Kenkel D; Jungraithmayr W; Pruessmann KP; Boss A
    Magn Reson Med; 2016 Jul; 76(1):156-62. PubMed ID: 26268414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast high-resolution brain imaging with balanced SSFP: Interpretation of quantitative magnetization transfer towards simple MTR.
    Garcia M; Gloor M; Radue EW; Stippich Ch; Wetzel SG; Scheffler K; Bieri O
    Neuroimage; 2012 Jan; 59(1):202-11. PubMed ID: 21820061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
    Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
    NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.